Showing 11 - 20 of 467
Reference price systems for prescription drugs constitute widely adopted cost containment tools. In these systems, patients co-pay a fraction of the difference between a drug's pharmacy retail price and a reference price that is set by the government. Reference prices are either determined...
Persistent link: https://www.econbiz.de/10009751931
Persistent link: https://www.econbiz.de/10009161181
Persistent link: https://www.econbiz.de/10011444382
Persistent link: https://www.econbiz.de/10011445504
Persistent link: https://www.econbiz.de/10012002450
Australia has a rich public-private mix of financing and provision of healthcare. Since mid-2015, the higher growth in out of pocket costs relative to the growth in wages began to reduce the affordability of private healthcare and marked the start of the drop in private health insurance...
Persistent link: https://www.econbiz.de/10012321080
Persistent link: https://www.econbiz.de/10014559041
Persistent link: https://www.econbiz.de/10015044861
Persistent link: https://www.econbiz.de/10015045064
The goal of this paper is to investigate and quantify the impact of parallel trade in markets for pharmaceuticals. The paper develops a structural model of demand and supply using data on prices, sales and characteristics of statins, medicines used in the treatment for high cholesterol, in...
Persistent link: https://www.econbiz.de/10014128993